Erythema News and Research

RSS
Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Mallinckrodt announces commercial launch of PENNSAID

Mallinckrodt announces commercial launch of PENNSAID

Erosive GERD treatments: an interview with Professor Joaquim Moraes-Filho, University of São Paulo Medical School

Erosive GERD treatments: an interview with Professor Joaquim Moraes-Filho, University of São Paulo Medical School

FDA approves New Drug Application for PENNSA 2%

FDA approves New Drug Application for PENNSA 2%

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Supraglottic index, teaching program validated

Supraglottic index, teaching program validated

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

Research: Sunscreen provides 100% protection against skin cancer

Research: Sunscreen provides 100% protection against skin cancer

European Commission approves Stivarga tablets for treatment of patients with mCRC

European Commission approves Stivarga tablets for treatment of patients with mCRC

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Clinical trial finds that sleep quality impacts skin function and aging

Clinical trial finds that sleep quality impacts skin function and aging

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting